Explore more publications!

Jefferies Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Jefferies Financial Group Inc. (NYSE: JEF). The investigation focuses on Jefferies’ executive officers and whether investor losses may be recovered under federal securities laws.

What if I purchased Jefferies securities?

If you purchased Jefferies securities and suffered losses on your investment, join our investigation now: Click here to join the investigation.

Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471.

There is no cost or obligation to you.

Background of the investigation

On October 8, 2025, The Financial Times published an article titled “Jefferies reveals $715mn fund exposure to First Brands invoices.” The article reported that Jefferies was under scrutiny for its relationship with collapsed car parts company First Brands and that Jefferies had provided invoice financing to the company while also advising First Brands and placing loans with other investors.

Following this disclosure, Jefferies’ share price declined approximately $4.66 per share, or 7.88%, to close at $54.44 per share on October 8, 2025.

On November 27, 2025, news reports indicated that the U.S. Securities and Exchange Commission was investigating Jefferies regarding its relationship with First Brands, including whether Jefferies provided sufficient disclosure to investors in its Point Bonita fund concerning exposure to First Brands.

Later, on January 7, 2026, The Financial Times reported that Jefferies took a $30 million loss tied to the collapse of First Brands. Following this report, Jefferies’ stock price declined approximately $3.62 per share, or 5.6%.

In light of this disclosure, Johnson Fistel is investigating whether Jefferies complied with the federal securities laws. If you suffered losses from your investment in Jefferies stock, contact Johnson Fistel.

About Johnson Fistel, PLLP | Securities Fraud & Investor Rights

Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits and also assists foreign investors who purchased shares on U.S. exchanges. To learn more, visit www.johnsonfistel.com.

Achievements

In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services. This recognition reflects the firm’s effectiveness in advocating for investors, having recovered approximately $90,725,000 for aggrieved clients in cases where it served as lead or co-lead counsel. This marks the eighth time the firm has been recognized as a top plaintiffs’ securities law firm in the United States, based on the total dollar value of final recoveries.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contact
Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101
James Baker, Investor Relations – or – Frank J. Johnson, Esq.
(619) 814-4471 | jimb@johnsonfistel.com | fjohnson@johnsonfistel.com


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions